Moderna and Merck's cancer vaccine trial results

Statements (6)

1. ● Neutral

   Moderna and Merck developed a personalized cancer vaccine that lowers melanoma recurrence by 42%.

   time.comOct 22, 2026 23:54 UTC
2. ● Neutral

   Merck and Moderna reported results on an experimental cancer vaccine that cuts the risk of melanoma recurrence

   nytimes.comOct 22, 2026 22:48 UTC
3. ▲ Bullish

   Moderna and Merck reported that their mRNA cancer vaccine reduced death and recurrence by 42%.

   arstechnica.comOct 22, 2026 22:12 UTCHigh importance
4. ● Neutral

   Moderna and Merck announced a significant result for their mRNA-based cancer vaccine developed in collaboration.

   portfolio.huOct 22, 2026 18:50 UTCHigh importance
5. ● Neutral

   Moderna is releasing trial results for its cancer vaccine.

   marketwatch.comOct 21, 2026 15:00 UTCHigh importance
6. ▲ Bullish

   Phase 3 cancer vaccine trial for Moderna is successful

   finance.yahoo.comOct 17, 2026 04:21 UTCHigh importance